解释治疗效果的比例:对解释的概述
Florian Stijven1, Ariel Alonso1, Geert Molenberghs2
1I-BioStat, KU Leuven, Leuven, Belgium.
Statistical methods in medical research
|July 25, 2024
概括
在临床试验中,解释替代终点治疗效果解释 (PTE) 的比例是具有挑战性的. 只有在强有力的,往往无法验证的假设下,PTE才是有意义的,这限制了它的实际应用.
科学领域:
- 临床试验 临床试验
- 生物统计学 生物统计学
- 流行病学 流行病学
背景情况:
- 在临床试验中选择主要终点对于成功至关重要.
- 替代终点经常被提议以取代真实终点,因为实际约束.
- 使用治疗效果解释 (PTE) 的比例评估代用终点有效性是常见的.
研究的目的:
- 审查和分析对治疗效果解释比例 (PTE) 的不同解释.
- 探索PTE,代孕,因果调解和试验级治疗效果预测之间的联系.
- 要突出与PTE解释相关的局限性和假设.
主要方法:
- 审查关于PTE解释的现有文献.
- 对PTE的因果和非因果框架的探索.
- 分析假设的疫苗试验数据以说明挑战.
主要成果:
- 确定了多种解释PTE的方法,包括因果和非因果方法.
- 证明了PTE,主要代孕和因果调解分析之间的联系.
- 强调所有PTE解释都依赖于强有力的,往往无法验证的假设.
结论:
- 解释治疗效果的比例 (PTE) 只有在非常强烈的假设下才有意义.
- 研究人员必须对PTE背后的假设保持谨慎和透明.
- 由于它依赖于无法验证的条件,PTE的实用性受到限制.
相关概念视频
Testing a Claim about Population Proportion
3.3K
A complete procedure for testing a claim about a population proportion is provided here.
There are two methods of testing a claim about a population proportion: (1) Using the sample proportion from the data where a binomial distribution is approximated to the normal distribution and (2) Using the binomial probabilities calculated from the data.
The first method uses normal distribution as an approximation to the binomial distribution. The requirements are as follows: sample size is large...
There are two methods of testing a claim about a population proportion: (1) Using the sample proportion from the data where a binomial distribution is approximated to the normal distribution and (2) Using the binomial probabilities calculated from the data.
The first method uses normal distribution as an approximation to the binomial distribution. The requirements are as follows: sample size is large...
3.3K
Regression Toward the Mean
6.3K
Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
6.3K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
125
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
125
Statistical Significance
20.1K
Once data is collected from both the experimental and the control groups, a statistical analysis is conducted to find out if there are meaningful differences between the two groups. A statistical analysis determines how likely any difference found is due to chance (and thus not meaningful). In psychology, group differences are considered meaningful, or significant, if the odds that these differences occurred by chance alone are 5 percent or less. Stated another way, if we repeated this...
20.1K
Odds Ratio
121
The odds ratio (OR) is a statistical measure used extensively in epidemiology and research to quantify the strength of association between exposure and outcome across different groups. Unlike relative risk, which compares the probabilities of an event occurring, the odds ratio compares the odds of an event occurring in the exposed group to the odds of it occurring in the unexposed group. The odds, in this context, are calculated as the probability of the event happening divided by the...
121
Hazard Ratio
108
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
108


